INNOVATIVE PHASE-1 STUDY DESIGN IN HEALTHY PARTICIPANTS TO ENABLE RAPID PROGRESSION OF A FIRST-IN-CLASS ORAL PROTEASE INHIBITOR PF-07321332 TO PIVOTAL TRIALS IN COVID-19 PATIENTS
Clinical Pharmacology & Therapeutics
; 111:S48-S48, 2022.
Article
in English
| Web of Science | ID: covidwho-1695340
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
Clinical Pharmacology & Therapeutics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS